Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Retigabine Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0181ML
Description
Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga in the US and Trobalt in the EU. This certified solution standard is suitable for use as starting material in calibrators and controls for LC/MS or GC/MS methods in clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring, or pharmaceutical research applications.
Specifications
| 75-05-8 , 150812-12-7 | |
| MFCD04307735 | |
| 1.0 mg/mL in acetonitrile | |
| Ampule | |
| 6°C (42.8°F) - closed cup (solvent) |
| C16H18FN3O2 | |
| UN 1648 3 / PGII | |
| 303.33 | |
| 1 mL |
Safety and Handling
H332-H319-H412
H312
EINECSNumber : 200-835-2
Recommended Storage : -20°C
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
CERILLIANT is a registered trademark of Cerilliant Corporation